These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 34269483)

  • 1. Cytosolic GDH1 degradation restricts protein synthesis to sustain tumor cell survival following amino acid deprivation.
    Shao J; Shi T; Yu H; Ding Y; Li L; Wang X; Wang X
    EMBO J; 2021 Oct; 40(20):e107480. PubMed ID: 34269483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PTPN13 acts as a tumor suppressor in clear cell renal cell carcinoma by inactivating Akt signaling.
    Long Q; Sun J; Lv J; Liang Y; Li H; Li X
    Exp Cell Res; 2020 Nov; 396(1):112286. PubMed ID: 32919955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA XLOC_006390 promotes pancreatic carcinogenesis and glutamate metabolism by stabilizing c-Myc.
    He J; Li F; Zhou Y; Hou X; Liu S; Li X; Zhang Y; Jing X; Yang L
    Cancer Lett; 2020 Jan; 469():419-428. PubMed ID: 31734356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. α-Ketoglutarate-Activated NF-κB Signaling Promotes Compensatory Glucose Uptake and Brain Tumor Development.
    Wang X; Liu R; Qu X; Yu H; Chu H; Zhang Y; Zhu W; Wu X; Gao H; Tao B; Li W; Liang J; Li G; Yang W
    Mol Cell; 2019 Oct; 76(1):148-162.e7. PubMed ID: 31447391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. JMJD2B-induced amino acid alterations enhance the survival of colorectal cancer cells under glucose-deprivation via autophagy.
    Tan J; Wang HL; Yang J; Liu QQ; Li CM; Wang YQ; Fu LN; Gao QY; Chen YX; Fang JY
    Theranostics; 2020; 10(13):5763-5777. PubMed ID: 32483417
    [No Abstract]   [Full Text] [Related]  

  • 6. LncRNA CDKN2B-AS1 stabilized by IGF2BP3 drives the malignancy of renal clear cell carcinoma through epigenetically activating NUF2 transcription.
    Xie X; Lin J; Fan X; Zhong Y; Chen Y; Liu K; Ren Y; Chen X; Lai D; Li X; Li Z; Tang A
    Cell Death Dis; 2021 Feb; 12(2):201. PubMed ID: 33608495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. G3BP1 promotes tumor progression and metastasis through IL-6/G3BP1/STAT3 signaling axis in renal cell carcinomas.
    Wang Y; Fu D; Chen Y; Su J; Wang Y; Li X; Zhai W; Niu Y; Yue D; Geng H
    Cell Death Dis; 2018 May; 9(5):501. PubMed ID: 29717134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MINA53 deficiency leads to glioblastoma cell apoptosis via inducing DNA replication stress and diminishing DNA damage response.
    Xuan F; Huang M; Zhao E; Cui H
    Cell Death Dis; 2018 Oct; 9(11):1062. PubMed ID: 30333481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitors of Jumonji C domain-containing histone lysine demethylases overcome cisplatin and paclitaxel resistance in non-small cell lung cancer through APC/Cdh1-dependent degradation of CtIP and PAF15.
    Duan L; Perez RE; Calhoun S; Maki CG
    Cancer Biol Ther; 2022 Dec; 23(1):65-75. PubMed ID: 35100078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wilms' tumor 1-associating protein promotes renal cell carcinoma proliferation by regulating CDK2 mRNA stability.
    Tang J; Wang F; Cheng G; Si S; Sun X; Han J; Yu H; Zhang W; Lv Q; Wei JF; Yang H
    J Exp Clin Cancer Res; 2018 Feb; 37(1):40. PubMed ID: 29482572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The interaction of YBX1 with G3BP1 promotes renal cell carcinoma cell metastasis via YBX1/G3BP1-SPP1- NF-κB signaling axis.
    Wang Y; Su J; Wang Y; Fu D; Ideozu JE; Geng H; Cui Q; Wang C; Chen R; Yu Y; Niu Y; Yue D
    J Exp Clin Cancer Res; 2019 Sep; 38(1):386. PubMed ID: 31481087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and significance of histone H3K27 demethylases in renal cell carcinoma.
    Shen Y; Guo X; Wang Y; Qiu W; Chang Y; Zhang A; Duan X
    BMC Cancer; 2012 Oct; 12():470. PubMed ID: 23057811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Redirected nuclear glutamate dehydrogenase supplies Tet3 with α-ketoglutarate in neurons.
    Traube FR; Özdemir D; Sahin H; Scheel C; Glück AF; Geserich AS; Oganesian S; Kostidis S; Iwan K; Rahimoff R; Giorgio G; Müller M; Spada F; Biel M; Cox J; Giera M; Michalakis S; Carell T
    Nat Commun; 2021 Jul; 12(1):4100. PubMed ID: 34215750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GSKJ4, an H3K27me3 demethylase inhibitor, effectively suppresses the breast cancer stem cells.
    Yan N; Xu L; Wu X; Zhang L; Fei X; Cao Y; Zhang F
    Exp Cell Res; 2017 Oct; 359(2):405-414. PubMed ID: 28823831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PPARα inhibition modulates multiple reprogrammed metabolic pathways in kidney cancer and attenuates tumor growth.
    Abu Aboud O; Donohoe D; Bultman S; Fitch M; Riiff T; Hellerstein M; Weiss RH
    Am J Physiol Cell Physiol; 2015 Jun; 308(11):C890-8. PubMed ID: 25810260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different expression patterns of histone H3K27 demethylases in renal cell carcinoma and bladder cancer.
    Hong Z; Li H; Li L; Wang W; Xu T
    Cancer Biomark; 2017; 18(2):125-131. PubMed ID: 27983522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cancer driver genes IDH1/2, JARID1C/ KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism.
    Chang S; Yim S; Park H
    Exp Mol Med; 2019 Jun; 51(6):1-17. PubMed ID: 31221981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MORC2 regulates DNA damage response through a PARP1-dependent pathway.
    Zhang L; Li DQ
    Nucleic Acids Res; 2019 Sep; 47(16):8502-8520. PubMed ID: 31616951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long noncoding RNA HOTAIR promotes metastasis of renal cell carcinoma by up-regulating histone H3K27 demethylase JMJD3.
    Xia M; Yao L; Zhang Q; Wang F; Mei H; Guo X; Huang W
    Oncotarget; 2017 Mar; 8(12):19795-19802. PubMed ID: 28177890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BRDT is a novel regulator of eIF4EBP1 in renal cell carcinoma.
    Wan P; Chen Z; Zhong W; Jiang H; Huang Z; Peng D; He Q; Chen N
    Oncol Rep; 2020 Dec; 44(6):2475-2486. PubMed ID: 33125143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.